प्लान में उपलब्ध है
एक साथ कई कंपनियों का विश्लेषण करना चाहते हैं? सशुल्क प्लान में आप अधिकतम 5 शेयरों की साथ-साथ तुलना कर सकते हैं।
साइन अप करें
B
099430
vs
K
KOSPI 200
पिछले 12 महीने में BioPlus Co Ltd ने KOSPI 200 से कमजोर प्रदर्शन किया। इसका रिटर्न -45% रहा, जबकि KOSPI 200 में +64% की वृद्धि हुई।
शेयरों का प्रदर्शन
099430 vs KOSPI 200
प्रदर्शन में अंतर
099430 vs KOSPI 200
वर्ष के अनुसार प्रदर्शन
099430 vs KOSPI 200
शेयर के रिटर्न की तुलना उसके बेंचमार्क सूचकांक और प्रतिस्पर्धियों से करें। समय के साथ उसके सापेक्ष प्रदर्शन को समझें।
BioPlus Co Ltd
एक नज़र में
BioPlus Co Ltd makes medical aesthetic products, especially hyaluronic acid-based dermal fillers used by doctors in cosmetic and reconstructive procedures. It also sells related beauty and skin-care products tied to the same anti-aging and tissue-care market. In simple terms, the company turns biomaterials into injectable products that help restore volume, smooth lines, and improve the look or feel of skin. Its main customers are clinics, hospitals, distributors, and other medical-aesthetics buyers, often through local and overseas sales channels. BioPlus makes money by selling finished products, and in some cases by supplying products through partners that market them under their own brands. That means its business depends on repeat orders from medical professionals and the regulatory approvals needed to sell these products in each market. What makes BioPlus different is that it sits in a niche part of healthcare where medicine and cosmetic treatment overlap. The company is not a drugmaker in the usual sense and not a general beauty company either; it sells physician-used products that are part of elective aesthetic care. That gives it a business model built around specialized formulations, medical distribution, and trusted use in clinics rather than mass retail.